𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cellular immune response and immunotoxicity induced by DON (deoxynivalenol) in piglets

✍ Scribed by L. Ferrari; A. M. Cantoni; P. Borghetti; E. De Angelis; A. Corradi

Publisher
Springer Netherlands
Year
2009
Tongue
English
Weight
68 KB
Volume
33
Category
Article
ISSN
0165-7380

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cellular and humoral anti-tumor immune r
Cellular and humoral anti-tumor immune responsiveness in chickens bearing tumors induced by avian sarcoma virus
✍ M. A. Wainberg; M. Yu; E. Schwartz-Luft; E. IsraΓ«l πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 French βš– 743 KB

## Abstract A systematic comparison was undertaken of the respective abilities of normal chicken embryo fibroblast (CEF) cells, Rous sarcoma virus (RSV)‐ transformed CEF cells, avian Rous sarcoma (RS) tumor cells and murine RS cells to serve as targets and antigen donors in various assays for the d

FTY720 ameliorates MOG-induced experimen
FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses
✍ Dimitrios Papadopoulos; Jon Rundle; Ryan Patel; Ian Marshall; Jennifer Stretton; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 593 KB

## Abstract FTY720, an oral sphingosine 1‐phosphate (S1P) receptor modulator, has shown efficacy in phase II trials in patients with relapsing‐remitting multiple sclerosis (MS). Although this molecule is thought to immunosuppress by inhibiting lymphocyte egress from the lymph nodes, the full spectr

Cellular and humoral immune responses in
Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen
✍ Fareed Rahman; Anja Dahmen; Sabine Herzog-Hauff; Wulf O. BΓΆcher; Peter R. Galle; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 1 views

The vaccination route may influence the success of immunization against pathogens. The conventional intramuscular (i.m.) application of a vaccine containing the hepatitis B virus (HBV) surface antigen (HBsAg) led to protective anti-HBs antibody levels in the majority of vaccine recipients. In this s